Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma

BACKGROUND: Clinically, Yu ping feng san (YPFS) has been extensively used as a medication for treating immune deficiency, and YPFS is combined with chemotherapy drugs to treat cancer, including hepatocellular carcinoma (HCC), lung cancer, and pancreatic cancer. Previous research has shown that YPFS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Qin, Yao, Fei, Zhou, Liang, Liang, Guoqiang, Song, Xiudao, Jiang, Guorong, Zhou, Man, Zhang, Lurong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925680/
https://www.ncbi.nlm.nih.gov/pubmed/31885639
http://dx.doi.org/10.1155/2019/1947156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925680/
https://www.ncbi.nlm.nih.gov/pubmed/31885639
http://dx.doi.org/10.1155/2019/1947156

Ejemplares similares